These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 25611258)
41. [Perspectives on immunotherapy for hepatocellular carcinoma]. Schmidt N; Büttner N; Thimme R Dtsch Med Wochenschr; 2013 Apr; 138(14):740-4. PubMed ID: 23533044 [TBL] [Abstract][Full Text] [Related]
42. [Immunotherapy for hepatocellular carcinoma using dendritic cells]. Homma S; Toda G; Ohno T Nihon Rinsho; 2001 Oct; 59 Suppl 6():693-8. PubMed ID: 11762039 [No Abstract] [Full Text] [Related]
43. Induction of anti-tumor immunity by dendritic cells transduced with FAT10 recombinant adenovirus in mice. Yang Z; Wu D; Zhou D; Jiao F; Yang W; Huan Y Cell Immunol; 2015 Jan; 293(1):17-21. PubMed ID: 25461613 [TBL] [Abstract][Full Text] [Related]
44. Improvement of HBsAg gene-modified dendritic cell-based vaccine efficacy by optimizing immunization method or the application of β-glucosylceramide. Long J; Zhou B; Li H; Dai Q; Zhang B; Xing S; Zeng Z; Chen W; Yang J Immunol Invest; 2013; 42(2):137-55. PubMed ID: 23323523 [TBL] [Abstract][Full Text] [Related]
45. [Comparison of antitumor effects of dendritic cells modified with different forms of hepatocellular cancer antigens]. He LX; Zhang GM; Feng ZH Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Jan; 21(1):100-2, 117. PubMed ID: 15629095 [TBL] [Abstract][Full Text] [Related]
51. [Infiltration of dendritic cells and lymphocytes in hepatocellular carcinoma tissue]. Yin X; Lu M; Liang L; Lai Y; Huang J; Li Z Zhonghua Wai Ke Za Zhi; 2002 May; 40(5):336-43. PubMed ID: 12133336 [TBL] [Abstract][Full Text] [Related]
52. Glypican3 in genetically modified human monocyte-derived dendritic cells induced specific cytotoxity against glypican3 overexpressing human hepatocellular carcinoma cells in vitro. Guo DW; Zhang SY; Hou XZ; Li HW; Jiang XF; Sun WY; We YT; Liang J Saudi Med J; 2008 Sep; 29(9):1235-40. PubMed ID: 18813403 [TBL] [Abstract][Full Text] [Related]
53. Frequency of CD45RO+ subset in CD4+CD25(high) regulatory T cells associated with progression of hepatocellular carcinoma. Takata Y; Nakamoto Y; Nakada A; Terashima T; Arihara F; Kitahara M; Kakinoki K; Arai K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S Cancer Lett; 2011 Aug; 307(2):165-73. PubMed ID: 21530074 [TBL] [Abstract][Full Text] [Related]
54. Comparative analysis of DC fused with tumor cells or transfected with tumor total RNA as potential cancer vaccines against hepatocellular carcinoma. Zhang HM; Zhang LW; Liu WC; Cheng J; Si XM; Ren J Cytotherapy; 2006; 8(6):580-8. PubMed ID: 17148035 [TBL] [Abstract][Full Text] [Related]
55. Potentiation of the immunotherapeutic effect of autologous dendritic cells by pretreating hepatocellular carcinoma with low-dose radiation. Lin CC; Wang TE; Liu CY; Lin CP; Liu TP; Chen MJ; Chang WH; Lin JC; Chang KM; Chu CH; Shih SC; Chao KS; Chen YJ Clin Invest Med; 2008; 31(3):E150-9. PubMed ID: 18544278 [TBL] [Abstract][Full Text] [Related]
56. Vaccination with dendritic cells pulsed with apoptotic cells elicits effective antitumor immunity in murine hepatoma models. Hayashi T; Nakao K; Nagayama Y; Saitoh O; Ichikawa T; Ishikawa H; Hamasaki K; Eguchi K; Ishii N Int J Oncol; 2005 May; 26(5):1313-9. PubMed ID: 15809723 [TBL] [Abstract][Full Text] [Related]
57. [Initial research of the effect and mechanism of cytotoxic T lymphocyte (lymphocyte) primed by dendritic cell as hepatocellular carcinoma vaccine]. Guo JW; Qin LW; Cai MY; Guo YB; Lu TD; Yu L Zhonghua Gan Zang Bing Za Zhi; 2003 Jul; 11(7):414, 417. PubMed ID: 12890344 [No Abstract] [Full Text] [Related]
58. Expansion of peripheral and intratumoral regulatory T-cells in hepatocellular carcinoma: a case-control study. Thakur S; Singla A; Chawla Y; Rajwanshi A; Kalra N; Arora SK Indian J Pathol Microbiol; 2011; 54(3):448-53. PubMed ID: 21934201 [TBL] [Abstract][Full Text] [Related]
59. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model. Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166 [TBL] [Abstract][Full Text] [Related]
60. Liver DCs in health and disease. Wirtz TH; Brandt EF; Berres ML Int Rev Cell Mol Biol; 2019; 348():263-299. PubMed ID: 31810555 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]